Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Oct 16, 2020 05:21PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
My understanding: When we were at 5 cents it was because of the connection to ZHCLF. When they disconnected we reverted back to ~2 bucks. I suspect the $2 was originally from them looking at past financings. Now at $1? I dunno. Maybe just time going by without valuation-boosting news? It's not ZHCLF again, which is at 7 cents. I've called and asked before where they get the valuation and they say it comes from some back room department and the rep has no access to that info. The only way it might affect me is what I pay for commissions and Advanced Dashboard which depends on total asset value.